The cost effectiveness of vancomycin for preventing infections after shoulder arthroplasty: a break-even analysis. [electronic resource]
- Journal of shoulder and elbow surgery Mar 2017
- 472-477 p. digital
Publication Type: Journal Article
1532-6500
10.1016/j.jse.2016.07.071 doi
Anti-Bacterial Agents--economics Antibiotic Prophylaxis--economics Arthroplasty, Replacement, Shoulder Cost-Benefit Analysis Humans Surgical Wound Infection--economics United States Vancomycin--economics